Shares of Aetna Inc (NYSE:AET) ended Friday session in red amid volatile trading. The shares closed down -0.99 points or -0.85% at $115.55 with 1,596,115 shares getting traded. Post opening the session at $115.89, the shares hit an intraday low of $115.36 and an intraday high of $116.49 and the price vacillated in this range throughout the day. The company has a market cap of $40.19 billion and the numbers of outstanding shares have been calculated to be 350.80 million shares.
On September 6, 2016 Aetna Inc (AET) and Piedmont Healthcare announced that the two organizations have signed a new contract. The agreement will give Aetna members continued in-network access to all Piedmont facilities and more than 1,400 Piedmont Clinic physicians through February 28, 2019.
“Our new contract is a testament to the strong, longstanding relationship we have with Piedmont Healthcare,” said Angela Meoli, Aetna market president, Georgia. “We have worked together for many years in support of a common cause: ensuring access to high-quality care and improving health for members of the Greater Atlanta community.”
“By partnering with Aetna on this agreement, our patients and their family members win,” said Kevin Brown, president and CEO of Piedmont Healthcare. “Not only will they be able to maintain their relationships with the Piedmont physicians they know and trust, they can rest assured knowing they have access to high-quality care.”
Piedmont Healthcare will participate in Aetna’s Institute of Excellence™ for adult liver, kidney and pancreas transplantation.
“Only hospitals that have met extensive quality and cost-effective criteria are selected by Aetna to participate in its Institutes of Excellence™ network,” said Mary Foote, head of Institutes Programs™ at Aetna. “All of our members now have access to Piedmont Healthcare as a world-class transplant facility.”
Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) ended Friday session in red amid volatile trading. The shares closed down -5.14 points or -3.95% at $124.92 with 1.55 million shares getting traded. Post opening the session at $128.32, the shares hit an intraday low of $123.95 and an intraday high of $129.27 and the price vacillated in this range throughout the day. The company has a market cap of $26.91 billion and the numbers of outstanding shares have been calculated to be 224.25 million shares.
Alexion Pharmaceuticals, Inc. (ALXN) announced that management will present at two upcoming investor conferences:
Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 13, 2016 at 9:10 a.m., Eastern Time.
LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology in New York on Wednesday, September 28, 2016 at 11:35 a.m., Eastern Time.
An audio webcast of each presentation will be available live. You can access the webcasts at: http://ir.alexionpharm.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.